EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis

Xin Fu iD, Chuang Liu, Ya-Li Chen, Jie-Lin Qin, Ting-Ting Wang, Shan-Shan Fu

The Kaohsiung Journal of Medical Sciences · 2025

DOI: 10.1002/kjm2.70106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Xin Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. Hauptthemen laut MEDLINE: Oxidative Stress, Atherosclerosis, Rosuvastatin Calcium, Plaque, Atherosclerotic. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rosuvastatin (RVS) is an HMG‐CoA reductase inhibitor with lipid‐lowering properties. This study aims to investigate the role of RVS in plaque formation in atherosclerosis (AS) and its functional mechanism. ApoE −/− mice were fed a high‐fat diet to generate a mouse model of AS. RVS treatment reduced serum levels of total cholesterol, triglycerides, and low‐density lipoprotein cholesterol in atherosclerotic mice, alleviated oxidative stress, and ameliorated lipid deposition, plaque formation, and fibrosis in the mouse aortic tissues. In vitro, it reduced reactive oxygen species and suppressed the proliferation and migration of oxidized low‐density lipoprotein‐challenged human vascular smooth muscle cells (HVSMCs). REST corepressor 1 (RCOR1) was identified as a target protein upregulated by RVS. It was found to repress transcription of decidual protein induced by progesterone 1 (DEPP1/C10ORF10) by binding to its promoter. Silencing of RCOR1 negated the AS‐ameliorating effects of RVS in mice and HVSMCs. However, the AS‐like symptoms in mice and HVSMC activity were suppressed by the additional C10ORF10 silencing. In conclusion, this study demonstrates that RVS alleviates oxidative stress and reduces atherosclerotic plaque formation by increasing RCOR1‐mediated transcriptional repression of C10ORF10.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressAtherosclerosisRosuvastatin CalciumPlaque, AtheroscleroticNuclear Receptor Co-Repressor 1AnimalsHumansMiceMaleUp-RegulationApolipoproteins EMyocytes, Smooth MuscleMice, Inbred C57BLDiet, High-FatReactive Oxygen SpeciesMuscle, Smooth, VascularDisease Models, AnimalTranscription, GeneticCell ProliferationAorta

Stichwörter der Autor:innen

C10ORF10HVSMCsRCOR1atherosclerosisrosuvastatin

Substanzen

Rosuvastatin CalciumNuclear Receptor Co-Repressor 1Apolipoproteins EReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
  • Department of Comprehensiveness, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.

ORCID-Profile: Xin Fu

Zitieren

APA

Fu, X., Liu, C., Chen, Y. L., Qin, J. L., Wang, T. T., & Fu, S. S. (2025). Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70106

Vancouver

Fu X, Liu C, Chen YL, Qin JL, Wang TT, Fu SS. Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70106

BibTeX
@article{Fu2025,
  author = {Fu, Xin and Liu, Chuang and Chen, Ya-Li and Qin, Jie-Lin and Wang, Ting-Ting and Fu, Shan-Shan},
  title = {Rosuvastatin Upregulates RCOR1 to Repress C10ORF10 Transcription and Alleviate Oxidative Stress and Plaque Formation in Atherosclerosis},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2025},
  doi = {10.1002/kjm2.70106}
}
Kostenlos starten →